These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27922229)

  • 1. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching monoamine oxidase inhibitors.
    True BL; Alexander B; Carter B
    Drug Intell Clin Pharm; 1985 Nov; 19(11):825-7. PubMed ID: 4064915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 5. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 6. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cocaine abuse with monoamine oxidase inhibitors.
    Brewer C
    Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAOIs - does the evidence warrant their resurrection?
    Menkes D; Bosanac P; Castle D
    Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.
    Blackwell B; Marley E; Price J; Taylor D
    Br J Psychiatry; 1967 Apr; 113(497):349-65. PubMed ID: 6034391
    [No Abstract]   [Full Text] [Related]  

  • 11. An operational evaluation of monoamine oxidase inhibitors.
    Blackwell B; Taylor D
    Proc R Soc Med; 1967 Aug; 60(8):830-4. PubMed ID: 6035423
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monoamine oxidase inhibitors as pharmaceutical agents].
    Cherkes OI; Chekman IS
    Farm Zh; 1969; 24(1):10-4. PubMed ID: 4389639
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors.
    De Villiers JC
    Br J Psychiatry; 1966 Feb; 112(483):109-18. PubMed ID: 5906469
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF; Thase ME
    J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
    Schottenfeld RS; O'Malley SS; Smith L; Rounsaville BJ; Jaffe JH
    Am J Drug Alcohol Abuse; 1989; 15(3):339-44. PubMed ID: 2669469
    [No Abstract]   [Full Text] [Related]  

  • 20. MAOIs and Ménière's syndrome.
    Mattes JA
    Am J Psychiatry; 1990 Apr; 147(4):534. PubMed ID: 2316744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.